Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

EU Getting Tougher On States Not Complying With Biotech Rules

July 30, 2003

By Peter O'Donnell

EU Getting Tougher On States Not Complying With Biotech Rules

July 30, 2003

By Peter O'Donnell

EU Planning Guidelines On Embryonic Stem Cell Research

July 16, 2003

By Peter O'Donnell

EU Planning Guidelines On Embryonic Stem Cell Research

July 16, 2003

By Peter O'Donnell

Tough New GMO Labeling Rules Could End Approval Moratorium

July 9, 2003

By Peter O'Donnell

Tough New GMO Labeling Rules Could End Approval Moratorium

July 9, 2003

By Peter O'Donnell

G10 Paper Calls For Changes, Balance In EU Debate On Drugs

July 2, 2003

By Peter O'Donnell

G10 Paper Calls For Changes, Balance In EU Debate On Drugs

July 2, 2003

By Peter O'Donnell

European Firms Seek Incentives; EuropaBio Wants EU Stock Market

June 25, 2003

By Peter O'Donnell

European Firms Seek Incentives; EuropaBio Wants EU Stock Market

June 25, 2003

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...